HeartFlow, Inc. HTFL

Company Overview

HeartFlow, Inc. is a medical technology company focused on non-invasive cardiovascular diagnostics and artificial intelligence–enabled cardiac care. The company develops software and imaging solutions designed to assist physicians in diagnosing and managing coronary artery disease (CAD), primarily through analysis of coronary computed tomography angiography (CCTA) scans. HeartFlow operates within the broader healthcare technology, digital diagnostics, cardiovascular imaging, and medical software industries. Its primary revenue drivers include sales of its cloud-based diagnostic services, software platforms, and associated clinical support offerings used by hospitals, imaging centers, and cardiovascular specialists.

The company is best known for the HeartFlow FFRCT Analysis, a non-invasive diagnostic tool that uses computational fluid dynamics and AI to evaluate blood flow and identify coronary artery blockages from standard CCTA scans. HeartFlow’s positioning is based on combining advanced machine learning, cloud computing, and clinically validated cardiovascular analytics to reduce unnecessary invasive procedures and improve diagnostic efficiency. Founded in 2007, the company evolved from academic and engineering research in computational modeling and cardiovascular imaging, later expanding through regulatory approvals, reimbursement adoption, and partnerships with healthcare systems and imaging providers in North America, Europe, and Asia-Pacific markets.